Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atul Lodh

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The American Journal of Gastroenterology|July 18, 2024
What Is the Skinny on This Unusual Esophageal Finding: A Rare Case of Esophageal Epidermoid MetaplasiaAtul Lodh, Goo Lee, Frederick H Weber
Case Reports in Hepatology|August 26, 2024
A Rare Case of <i>Pseudomonas aeruginosa</i>-Associated Diarrhea in a Cirrhotic PatientMalcolm Chapman, Atul Lodh, Joven Tristeza, et al.
Epigenetics & Chromatin|July 4, 2019
MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALLCandace J Poole, Atul Lodh, Jeong-Hyeon Choi, et al.
Urology|October 5, 2019
EDITORIAL COMMENTJohn Z Benton, Atul Lodh, Christopher J D Wallis, et al.
Lung India : Official Organ of Indian Chest Society|July 14, 2021
Mystery in the mediastinum: Rare case of indolent primary thoracic amyloidsRohit Munagala, Pranjal Mishra, Atul Lodh, et al.
Cancers|November 21, 2018
Targeting the MYC Oncogene in Burkitt Lymphoma through HSP90 InhibitionCandace J Poole, Wenli Zheng, Haesung Lee, et al.
Cancers|June 19, 2024
Immune Checkpoint Inhibitors in Hepatocellular Carcinoma and Their Hepatic-Related Side Effects: A ReviewThomas M Ruli, Ethan D Pollack, Atul Lodh, et al.
Oncotarget|November 5, 2017
DNMT3B overexpression contributes to aberrant DNA methylation and MYC-driven tumor maintenance in T-ALL and Burkitt's lymphomaCandace J Poole, Wenli Zheng, Atul Lodh, et al.
Preventive Medicine|April 5, 2020
The association between physician trust and smoking cessation: Implications for motivational interviewingJohn Z Benton, Atul Lodh, Archibald M Watson, et al.
Urologic Oncology|March 26, 2021
Pathologic upgrading in favorable intermediate risk active surveillance patients: Clinical heterogeneity and implications for active surveillance decisionRashid K Sayyid, William C Reed, John Z Benton, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The American Journal of Gastroenterology|July 18, 2024
What Is the Skinny on This Unusual Esophageal Finding: A Rare Case of Esophageal Epidermoid MetaplasiaAtul Lodh, Goo Lee, Frederick H Weber
Case Reports in Hepatology|August 26, 2024
A Rare Case of <i>Pseudomonas aeruginosa</i>-Associated Diarrhea in a Cirrhotic PatientMalcolm Chapman, Atul Lodh, Joven Tristeza, et al.
Epigenetics & Chromatin|July 4, 2019
MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALLCandace J Poole, Atul Lodh, Jeong-Hyeon Choi, et al.
Urology|October 5, 2019
EDITORIAL COMMENTJohn Z Benton, Atul Lodh, Christopher J D Wallis, et al.
Lung India : Official Organ of Indian Chest Society|July 14, 2021
Mystery in the mediastinum: Rare case of indolent primary thoracic amyloidsRohit Munagala, Pranjal Mishra, Atul Lodh, et al.
Cancers|November 21, 2018
Targeting the MYC Oncogene in Burkitt Lymphoma through HSP90 InhibitionCandace J Poole, Wenli Zheng, Haesung Lee, et al.
Cancers|June 19, 2024
Immune Checkpoint Inhibitors in Hepatocellular Carcinoma and Their Hepatic-Related Side Effects: A ReviewThomas M Ruli, Ethan D Pollack, Atul Lodh, et al.
Oncotarget|November 5, 2017
DNMT3B overexpression contributes to aberrant DNA methylation and MYC-driven tumor maintenance in T-ALL and Burkitt's lymphomaCandace J Poole, Wenli Zheng, Atul Lodh, et al.
Preventive Medicine|April 5, 2020
The association between physician trust and smoking cessation: Implications for motivational interviewingJohn Z Benton, Atul Lodh, Archibald M Watson, et al.
Urologic Oncology|March 26, 2021
Pathologic upgrading in favorable intermediate risk active surveillance patients: Clinical heterogeneity and implications for active surveillance decisionRashid K Sayyid, William C Reed, John Z Benton, et al.
Pageof 2